A
Aude Nassif
Researcher at Pasteur Institute
Publications - 48
Citations - 1381
Aude Nassif is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Hidradenitis suppurativa & Medicine. The author has an hindex of 17, co-authored 40 publications receiving 969 citations. Previous affiliations of Aude Nassif include Necker-Enfants Malades Hospital.
Papers
More filters
Journal ArticleDOI
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project
Amit Garg,Erica Neuren,Denny Cha,Joslyn S. Kirby,John R. Ingram,Gregor B.E. Jemec,Solveig Esmann,L. Thorlacius,B. Villumsen,Véronique Del Marmol,Aude Nassif,Maïa Delage,Thrasyvoulos Tzellos,Dagfinn Moseng,Øystein Grimstad,Haley B. Naik,Robert G. Micheletti,S. Guilbault,Angie Parks Miller,Iltefat H. Hamzavi,Hessel H. van der Zee,Errol P. Prens,Naomi Kappe,Christine B. Ardon,Brian Kirby,R. Hughes,Christos C. Zouboulis,Georgios Nikolakis,Falk G. Bechara,Lukasz Matusiak,Jacek C Szepietowski,Amelia Głowaczewska,Saxon D Smith,Noah Goldfarb,Steven Daveluy,Christina Avgoustou,Evangelos J. Giamarellos-Bourboulis,Steven R. Cohen,Yssra Soliman,Elena Gonzalez Brant,Oleg E. Akilov,Christopher Sayed,Jerry Tan,Afsaneh Alavi,Michelle A. Lowes,José C. Pascual,Hassan Riad,Shani Fisher,Arnon D. Cohen,So Yeon Paek,Barry I. Resnik,Qiang Ju,Lanqi Wang,Andrew Strunk +53 more
TL;DR: HS patients have identified several critical unmet needs that will require stakeholder collaboration to meaningfully address in multidisciplinary care, treatment, research, advocacy, and philanthropy.
Journal ArticleDOI
Efficacy of Rifampin-Moxifloxacin-Metronidazole Combination Therapy in Hidradenitis Suppurativa
Olivier Join-Lambert,H. Coignard,Jean-Philippe Jais,Hélène Guet-Revillet,Sylvain Poirée,Sylvie Fraitag,Vincent Jullien,Florence Ribadeau-Dumas,Jacques Thèze,Anne-Sophie Le Guern,Sylvie Behillil,Anne Leflèche,Patrick Berche,Paul Henri Consigny,Olivier Lortholary,Xavier Nassif,Aude Nassif +16 more
TL;DR: Assessment of the efficacy and safety of a combination of oral rifampin, moxifloxacin and metronidazole in long-lasting refractory HS found Hurley staging is a prognostic factor of response to the treatment.
Journal ArticleDOI
Bacterial Pathogens Associated with Hidradenitis Suppurativa, France
Hélène Guet-Revillet,Hélène Coignard-Biehler,Jean-Philippe Jais,Gilles Quesne,Eric Frapy,Sylvain Poirée,Anne-Sophie Le Guern,Anne Le Flèche-Matéos,Alain Hovnanian,Paul-Henry Consigny,Olivier Lortholary,Xavier Nassif,Aude Nassif,Olivier Join-Lambert +13 more
TL;DR: Staphylococcus lugdunensis and anaerobic actinomycetes are associated with this skin infection.
Journal ArticleDOI
Hidradenitis Suppurativa Associated with Spondyloarthritis — Results from a Multicenter National Prospective Study
Pascal Richette,Anna Molto,Manuel Viguier,K. Dawidowicz,Gilles Hayem,Aude Nassif,Daniel Wendling,F. Aubin,F Lioté,Hervé Bachelez +9 more
TL;DR: SpA may occur in patients with HS, with the prevalence in this group exceeding that in the general population, and the very short time between skin and joint symptom onset in some cases suggests common pathogenic mechanisms underlying HS and SpA.
Journal ArticleDOI
The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study.
Hélène Guet-Revillet,Jean-Philippe Jais,Jean-Philippe Jais,Marie-Noëlle Ungeheuer,Hélène Coignard-Biehler,Hélène Coignard-Biehler,S. Duchatelet,S. Duchatelet,Maïa Delage,Thi Lam,Thi Lam,Alain Hovnanian,Alain Hovnanian,Olivier Lortholary,Olivier Lortholary,Xavier Nassif,Aude Nassif,Aude Nassif,Olivier Join-Lambert +18 more
TL;DR: The high prevalence and particular landscape of mixed anaerobic infection in HS is revealed, paving the way for rationale targeted antimicrobial treatments.